Monday, December 7, 2009

FDA Approves Lilly's Zyprexa for Two Adolescent Indications

The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years old.

The details can be read here.

1 comment:

Daniel Haszard said...

Eli Lilly sells a drug (Zyprexa) that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!

Eli Lilly has made $38 billion on Zyprexa and it was way oversold and caused diabetes and in some cases sudden death.
Eli Lilly has received a huge criminal fine over their Zyprexa cash cow,add it all up comes to $4.6 billion, in Zyprexa settlements,fines,litigation.

Did you know that Lilly made $ billions last year on diabetic meds, Actos,Humulin and Byetta?

They sell a drug that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!

—-
Daniel Haszard Zyprexa whistle-blower